A B S T R A C T The effect of aggregation and secretion on membrane proteins was studied in washed human platelets. Reversible aggregation without secretion was stimulated by ADP and secretion without aggregation was stimulated by thrombin in the presence ofEDTA. No loss ofplatelet surface glycoproteins occurred during reversible ADP-induced platelet aggregation, as measured by quantitative polyacrylamide gel electrophoresis analysis of platelets that were labeled with 125I-diazotized diiodosulfanilic acid (DD'25ISA) before ADP stimulation. Also, no new proteins became exposed on the platelet surface after ADP aggregation, as determined by DD'25ISA labeling after stimulation. Thrombin-induced platelet secretion also caused no loss of platelet surface glycoproteins. However, after platelet secretion two new proteins were labeled by DD'25ISA: (a) actin and (b) the 149,000-mol wt glycoprotein (termed GP-G), which is contained in platelet granules and secreted in response to thrombin. The identity of DD'25ISA-labeled actin was confirmed by four criteria: (a) comigration with actin in three different sodium dodecyl sulfate-polyacrylamide gel electrophoresis systems, (b) elution from a particulate fraction in low ionic strength buffer, (c) co-migration with actin in isoelectric focusing, and (d) binding to DNase I. The identity of actin and its appearance on the platelet surface after thrombininduced secretion was also demonstrated by the greater binding of an anti-actin antibody to thrombin-tTeated platelets, measured with 1251-staphylococcal protein A.
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Therefore, major platelet membrane changes occur after secretion but not after reversible aggregation. The platelet surface changes occurring with secretion A preliminary report of this study was presented to the American Heart Association in November 1978. Circulation. 68: II-217.
INTRODUCTION
Blood platelets change dramatically from their circulating state during involvement in hemostasis and thrombosis (1, 2) . They transform from disks to spheres with long pseudopods, aggregate with adjacent platelets, secrete their granule contents into the surrounding environment, accelerate plasma coagulation, and finally bind the developing fibrin strands and provide the power for clot retraction. Since these events must be associated with changes on the platelet membrane, we studied membrane surface proteins during two separable platelet activities: aggregation and secretion. Our studies examined two questions about these reactions. Is surface glycoprotein material lost from platelets during these reactions? Are new proteins exposed on the platelet surface after these reactions?
METHODS
Blood samples were obtained from normal volunteers, with informed consent, and platelets were isolated as described (3). For one experiment, blood was drawn from a patient with congenital Factor V deficiency (E.N.), who has been studied extensively (4) Stimulationi of DD'25ISA-labeled platelets wvithl thlro,nibini. Platelets were isolated from platelet-rich plasma, washed three times in RCD-PGE1, and labeled with DD'251SA. Then the labeled platelets were washed once in Tyrode's-PGE1, pH 6.5, and resuspended to 2 x 109/ml in 1 ml of Tyrode's-EDTA (4 (8) , staining, and (quantitative analysis of the SDS-PAGE data were performed as described (3) .
Molecular weight standards were rabbit muscle myosin (200,000), 8-galactosidase (130,000), bovine serumii albumin (68,000), and ovalbunmin (43,000) (3). Quantitation of the periodic acid-Schiff (PAS) reaction was performed by planimetry of the gel scanls. Platelet glvcoprotein peaks wvere converted to "PAS units" by dividing the area of each peak by the area of anl internial fetuin (Sigma Chenmical Co.) standard (3) . The percentage of glycoprotein(GP)-G secretioni wvas caleulated by this planimetry method (3). The PASstaining GP bands and the 40,000-mol wt band containiing actin, identifiable as a denise white precipitate in the PASstainied gel, were marked on the gel wvith ink, the gel was cut into 1-mmil slices, and the radioactivity quantified as described (3) . DD'251SA bound to GP-G or the 40,000-mol wt protein was expressed as a fraction of the radioactivity in the four major membranie GP on the samle gel. In one experimiienit, analysis of DD125ISA-labeled samples was performiied using 1.2-mnm thick slab gels by modificatioins (9) of the SDS-PAGE systems described bv Weber and Osborn (8), Laemmilli (10) , and Neville (11) . Proteini staininig and autoradiography were performedl as described (9 (14) . To the extract (1.5 mg proteiin/mIl) urea (9.5 MI, ultra-pure, Schwarz/Mainin, Div., Becton, Dickinson & Co., Orangeburg, N. Y.), nonidet P-40 (2%, Particle Data, Inc., Elmhurst, Ill.), dithiothreitol (40 mnMI), SDS (0.2%, Pierce Chemiiical Co., Rockford, Ill.), and ampholinies (40/c; Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) were added to a final concentration. The amiipholinies were a mixture of e(Iual parts of two pH ranges, 4.0-6.0 and 6.0-8.0. The sample was then heated to 100°C for 5 min. Polyacrylamiiide gels, sample overlay solution, and electrode solutions were prepared according to O'Farrell (13), except that ampholine concenitrationi was inereased to 4%. 7-cm,. long gels were formedl in 3-miml Diaml plastic tubes and isoelectric foeusinig was performed in a gel electrofocusing chamber (Medical Research Apparatus Corp., Clearwater, Fla.) at 300 V for 7 h. The pH gradient for each experiment was determinied from two blank gels (identical except for the absence of sample protein) cut into 5-mm sections and eluted in 1 ml of 10 mniM KCI for 20 min. Gels were stained with Coomassie Blue (3) after rinsinig for 48 h in 25% isopropanol, 10% acetic acid and then cut into 2.5 mmil-sectionis for determination of radioactivity.
DNase affitnitt, chromlatography. DNase affinity chromatography was performed using DNase I (Sigma Chenmical Co., DN-CL type I, bovine pancreas) conjugated to Sepharose 6B-CL (2 mg/ml of Sepharose beads) (15). 1 ml of the samlle 0.3 mM phosphate extract described above was applied to a 2 ml DNase-Sepharose columlin, which was then washed with 25 ml of 0.3 mNI phosphate, pH 7.6, before elution with 3.0 NI guanidine-HCl in 0.5 M sodium acetate, 10 mNI Tris-HCI, 0.5 mnM ATP, and 0.5 mNi CaCl2, pH 7.5 (15) (referred to as 3 NI guanidine buffer).
Platelet lysis. Platelet lysis was quantified by the 1'Cr release method of Aster and Enright (16) . Platelets were handled exactly as described above for thrombin treatmelnt except that they were labeled with 50 ,uCi of 5'Cr (Na51CrO4, Detection of platelet-bounrd immunoglobulin (Ig)G with "51-staphylococcal proteini A (1251-SPA). Anti-actin antibody (AAA) was a gift of Professor Giulio Gabbiani (Geneva, Switzerland). The antibody was isolated from the serum of a patient with chronic active hepatitis by affinity chromatography on Sepharose-rabbit skeletal muscle actin and has been used in several studies (17) (18) (19) . Rabbit anti-human platelet antiserum was prepared by immunizing rabbits with washed whole platelets emulsified in Freund's adjuvant. Nonimmune human IgG was purified by DEAE-cellulose chromatography.
The use of "251-SPA to quantify IgG bound to fixed cells in microtiter plates was developed by Zeltzer et al. (20, 21) and this method has recently been adapted to the study ofplatelets by Spiva and Zeltzer (22 (23) .
RESULTS
In the first part of this study, four basic experiments were performed: (a) stimulation of DD'25ISA-labeled platelets with ADP, (b) labeling of platelets with DD1251SA after ADP stimulation, (c) stimulation of DD1251SA-labeled platelets with thrombin, and (d) labeling of platelets with DD125ISA after thrombin stimulation. In each experiment platelets were analyzed by quantitative SDS-PAGE (3). Fig. 1 shows the pattern of the PAS stain of normal whole platelets and the fetuin standard. GP-G is the major GP of platelet granules and is secreted during the platelet release reaction (3, 24) . It has also been termed "thrombin-sensitive protein" (25 and "thrombospondin" (26) .
Effect of ADP-induced platelet aggregation on platelet nmembrane proteins. No significant loss of surface GP occurred during the reversible aggregation unaccompanied by platelet secretion caused by ADP stimulation of DD125ISA-labeled platelets, as determined by PAS staining and DD125ISA labeling (six experiments, P > 0.1). Also, no change in the pattern of radioisotope labeling was observed when DD125ISA was reacted with platelets that had previously undergone aggregation and disaggregation (three experi- and not seen regularly enough to be quantitatively analyzed.
ments, P > 0.5). Specifically, no new DD125ISA-labeled peaks were present in the gel slices containing GP-G and actin (Table I) . Effect of thrombin-induced platelet secretion on platelet membrane proteins. Platelet secretion of The data are the mean values (±SD) for four experiments in which platelets were labeled with DD125ISA after reversible ADP aggregation and eight experiments in which platelets were labeled with DD125ISA after thrombin-induced secretion. Release of GP-G was 61±16% (SD) with thrombin but did not occur with ADP. There was no difference in labeling of either actin or GP-G between ADP-treated platelets and their controls (P > 0.5). In contrast, the DD125ISA bound to either actin or GP-C after thrombin treatment was significantly greater than control values (P < 0.001).
Membrane Changes During Platelet Activation Fig. 2) . We considered the possibility that the change of DD125ISA labeling after thrombin stimulation might be due to lysis of a small fraction of platelets rather than exposure of new proteins on the membrane surface. This possibility was ruled out in two ways.
First, the amount of platelet lysis was directly assessed by 5'Cr release during each of the steps of thrombin treatment and subsequent DD125ISA labeling. 5GCr release was not different in thrombin-treated and control platelets (thrombin-treated, 2.0+0.3%; control, 1.8±0.4%; SD, n = 4). Second, the DD125ISA labeling pattern of sonicated platelets was compared to that of thrombin-treated platelets. After lysis by sonication an actin-region protein was the most prominent peak, however none of the other major DD125ISA peaks of lysed platelets coincided with proteins that were labeled after thrombin. We calculated that the DD-1251SA peaks seen in the platelet sonicate would have been readily apparent if the actin peak after thrombin stimulation was the result of cell lysis. 
-
Identification of GP-G and actin as the proteins appearing on the platelet surface after thrombininduced secretion. The new 149,000 mol wt DD-1251SA-labeled peak observed after thrombin secretion was identified as GP-G because of its exact and consistent correlation with the GP-G PAS band. Because the appearance of GP-G on the platelet surface after secretion, its molecular weight, and its GP nature were all reminiscent of coagulation Factor V (4, 27, 28), we speculated that GP-G could be coagulation Factor V and studied the platelets from a patient who had previously been demonstrated to have no platelet Factor V activity (4). The PAS and Coomassie stain patterns of platelets from this patient were normal in both unreduced and reduced SDS-PAGE analyses both before and after thrombin treatment. After secretion both GP-G and the actin-region protein were labeled by DD'251SA. Therefore, GP-G is likely not platelet Factor V.
Although actin is the major component of the dense 40,000-mol wt protein band of platelets analyzed by SDS-PAGE, this region may also contain several other proteins (9) . Therefore, experiments were performed to identify this DD1251SA peak as actin. Some platelet proteins in this molecular weight region, but not actin, migrate at different apparent molecular weights in different SDS-PAGE systems (9) . Fig. 3 demonstrates that the DD'25ISA peak comigrated with actin in three different SDS-PAGE systems. Fig. 4A demonstrates that the 40,000-mol wt DD125ISA peak was associated with a particulate fraction and was eluted in a low ionic strength buffer previously demonstrated to preferentially solubilize actin from membranes (12) . Fig. 4B demonstrates that the isoelectric point ofthis DD'25ISA peak was identical to that of actin. (9) and is marked by the arrows.
point of the radioactive peak, which coincided with the major Coomassie-stained protein band, was 5.78 (see Fig. 4 , gel P). This also coincided with one of the two bands present after isoelectric focusing of a preparation of homogeneous platelet actin (Fig. 4, gel A) . The other band in the actin sample had an isoelectric point of 5.43. These two bands may represent the previously reported fy and /8 forms of platelet actin (29) . Actin binds with high affinity to DNase I and can be eluted with 3 M guanidine (15) . For DNase I affinity experiments, the same 0.3 mM phosphate extract as shown in Fig. 4A was used. Fig. 5 demonstrates that this DD125ISA-labeled protein bound to DNase I and was eluted by 3 M guanidine. In three experiments, the fraction of counts per minute bound to DNase I was 84+12% (SD). A 0.3 mM phosphate extract of DD125ISA-labeled control platelets (thrombin omitted) contained strikingly less counts per minute with the ability to bind to DNase I (Fig. 5 ). Identification and quantification of platelet surface actin using an AAA. A specific AAA isolated from human serum (17) (18) (19) was reacted with thrombintreated and control platelets and antibody binding was quantified using 1251-SPA. 125I-SPA binds specifically to the Fc portion of IgG (30) and therefore can be used as a sensitive reagent for the detection of platelet-bound antibody (20-22, 30, 31) . Table II demonstrates that thrombin-treated platelets bound significantly more AAA than control platelets. In contrast, binding of nonimmune IgG and a rabbit anti-platelet antibody was the same in both thrombin-treated and control platelets. These experiments confirmed the appearance of actin on the platelet surface after thrombininduced secretion.
DISCUSSION
The occurrence of platelet membrane changes during activation has been demonstrated by changes in a variety of platelet functions, such as increased adhesiveness to subendothelium (32) and acceleration of coagulation (4) . To characterize the membrane surface protein changes that accompany platelet activation, we used washed human platelets in conditions that allowed independent assessment oftwo major platelet reactions: aggregation and secretion.
Effect of aggregation on platelet membrane proteins. Our studies demonstrated no loss of platelet surface GP during reversible ADP-induced platelet aggregation without secretion. Also we demonstrated no change in the DD125ISA labeling of membrane GP and no exposure of new proteins on the membrane surface after reversible aggregation, similar to the results of Jenkins et al. (33) using lactoperoxidase-catalyzed iodination. These results with human platelets in vitro are analogous to our in vivo studies of circulating rabbit platelets double-labeled with DD-1251SA for surface GP (34) and 5"Cr for internal cytoplasm. When these rabbits were given intravenous ADP, two-thirds of their platelets were removed from the circulation in less than 1 min but all returned to the circulation by 3 min. There was no loss of platelet surface GP during this reversible ADP-induced sequestration (35) . Therefore platelets may be able to resume their normal function in the circulation after transient aggregation. The recovery ofthe platelet membrane to a normally reactive state after reversible aggregation is also suggested by the response ofexperimental animals to repeated ADP infusions, with no apparent loss of platelet sensitivity to aggregation (36) .
Effect of secretion on platelet membrane proteins. Our studies demonstrated no loss ofplatelet surface GP during thrombin-induced secretion (without aggregation). These results are similar to those of Hagen et al. (37) who studied platelets labeled with [125I]lactoperoxidase. Our results differ from those of Phillips and Agin (38, 39) and Mosher et al. (40) , but different experimental systems were used in those studies.
Although there was no change in DD125ISA labeling ofthe membrane GP after thrombin-induced secretion, two new proteins were labeled: actin and the major granule GP, GP was not related to platelet lysis since the percent lysis was the same in both thrombin-treated and control platelets. Also, the post-secretion labeling pattern was different from the DD'251SA labeling pattern of lysed platelets. The appearance of new proteiins on the platelet surface after secretion is coinsistent with previous observations of the appearance of Factor V activity (2, 27) , lentil phytohemagglutinin binding sites (41) , and lectin activity (42) on the platelet membrane surface after thrombin treatment. GP-G was first described as a platelet protein released into superinatant fluid by thrombin-induced secretion, and termed thrombin-sensitive protein (25) . GP-G was iinitially considered to be a membrane protein because it remained with the platelet particulate fraction after a sonication procedure that completely solubilized a lyzosomal enzyme, f3-glucuronidase (25) .
Subse(luently, GP-G has been demonstrated to be a secreted granule protein (24, 26) . The appearance of GP-G on the platelet surface may be due to adsorption of secreted GP-G onto the membrane, or related to the process of granule fusioni with the plasma membrane durinig secretion (43) , if some GP-G remains adherent to the internal surface of the granule membrane.
Idenitificationi of actinl otn the platelet surface after throinbin-iniduced secretion. The appearance of actin on the platelet surface after thrombin-induced secretion was demonstrated by two independent methods: (a) labeling with DD125ISA and (b) binding of AAA. Four sets of experiments suggested the 40,000-mol wt protein labeled by DD'251SA after secretion was actin: (a) The labeled protein comigrated with actin in three different SDS-PAGE systems (8, 10, 11 (9) . The most dense protein band on the platelet sample was marked, and then the gel was sliced for determination of radioactivity. The peak of radioactivity occurred in the marked gel slice (A on the abscissa of the counts per ininute graph). The pH gradient was determined from slices of two simultaneouis blank gels. (15) . Our experiments with a specific AAA (17) (18) (19) also demonstrated the appearance of actin on the platelet surface after thrombin-induced secretion, and therefore strongly supported the data that the 40,000-mol wt protein labeled by DD'251SA is actin. Actin is a membrane-associated protein in many cells with postulated functions in the regulation of cell shape and cell motility (44, 45) . The intimate association of actin filaments and surface membranes has been shown by freeze-fracture studies of choroid plexus and intestinal microvilli: the microfilaments were predominantly attached to the exposed surface of the external half-membrane and therefore penetrated the internal half-membrane (46) . Although actin is not normally considered to be a cell surface protein, it has been detected on the external surface of lymphocytes by lactoperoxidase-catalyzed iodination (47) and two studies vith immunofluorescent techni(lues have suggested the appearance of actin on the surface of human platelets during activation (48, 49) .
Alpha actinin functions as the membrane attachment site for actin microfilaments in the tips of intestinal microvilli (50, 51) . Evidence has been presented that platelet membrane GP Illa may be aactinin (52) . Since this GP may span the plasma membrane (38) , it could function to anchor actin to the membrane and mediate the exposure of actin on the platelet surface. Therefore we studied platelets from four patients with Glanzmann's thrombastheniia, which are deficient in GP Illa and therefore, deficient in alpha actinin (52) (53) (54) . Our preliminary data (55, plus observations on two more patients) demonstrated that these platelets released GP-G nornmally in response to thrombin and after thrombin treatment GP-G was normally labeled by DD125ISA. However, there was significantly less increase in actin labeling by DD125ISA after thronmbin treatment in the thrombasthenic platelets than in normals. This is consistent with a hypothesis that membrane GP Illa (a-actinin) may bind actin within the plasma membrane and that during thrombin-induced platelet activation GP IlIa may undergo a conformational change to expose actin to the external environment. Once exposed on the platelet surface, actin could provide a receptor site for polymerizing fibrin (56, 57) and the contractile power for clot retraction. The diminished or absent clot retraction in Glanzmann's thrombasthenia (58) may be related to the diminished actin exposure on the surface of thrombasthenic platelets after thrombin treatment.
